aBstract Depressive illnesses are common in the general population and are significantly more common in those with physical illnesses. The symptoms of depression may go unrecognised in medical patients, with consequent underdiagnosis and under-treatment. Co-morbid depression is associated with increased morbidity, poorer function, increased healthcare costs and increased mortality. Depressive illnesses are amenable to treatment by both pharmacological and psychological means. Successful treatment can result in improved quality of life as well as improved function, mortality and overall outcome in the physical disorder. It is therefore important that medical doctors are aware of the symptoms, diagnosis and management of depressive illness.
Depressive illness is a disorder of mood where there is sustained pervasive low mood and anhedonia (loss of the ability to experience pleasure). These core symptoms are often associated with biological depressive features such as disturbed sleep, loss of appetite, impaired concentration and memory and lack of libido. The thoughts of depressed patients can come to be dominated by depressive cognitions -persistently gloomy thoughts and a negative appraisal of both the current situation and the future. At their most extreme these thoughts can give rise to hopelessness and thoughts or plans for suicide. Depressive illnesses can be of very variable severity, from mild and transient to severe and prolonged. Short-lived depressive symptoms are within the range of normal experience; they are of diagnostic significance if they are present for more than two weeks and of sufficient severity to interfere with normal activities.
Depression in the physically ill
Depressive illnesses are more common in patients with physical illness than those without. Prevalence rates for depression are ~5% in primary care patients, ~10% in medical outpatients and 10-20% in medical inpatients (with some studies reporting rates as high as 30%). Rates of depression tend to increase with the severity of the medical illness: for example, rates are high in patients in the aftermath of myocardial infarction, but similar to general population levels for those with mild angina or hypertension.
Physically ill patients with co-morbid depression have increased morbidity related to the depressive illness itself as well as occasional mortality via suicide. Additionally these patients have morbidity related to decreased compliance with medical treatment, reduced overall quality of life, reduced functional levels and increased overall mortality compared with nondepressed controls. They are also found to have longer hospital stays and increased healthcare costs.
Identification and treatment of depressive illness is more difficult in those with physical illness (see Table 1 ), but successful treatment offers the possibility of decreased psychological morbidity, reduced healthcare costs, improved compliance and participation in rehabilitation, and reduced overall mortality.
The co-occurrence of depression and physical illness can arise in a number of ways. Firstly, the physical illness can cause or exacerbate the depression; secondly, the depression can cause or exacerbate the physical illness; and, thirdly, the two can have a common cause. Additionally, any co-occurrence may be coincidental as depressive illnesses are common and can be expected to co-occur with other common physical illnesses from time to time.
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Depression caused or exacerbated by physical illness
Physical illness can cause depression either by a (presumed) direct biological effect, via psychological factors related to the physical disease or via the depressant effects of the treatment or treatment side effects.
• Biological effect A presumed direct biological effect may arise via the endocrine system (e. 
Physical illness caused or exacerbated by depression
Physical illness can be directly attributable to a depressive illness, e.g. fulminant hepatic failure following paracetamol overdose taken during a depressive relapse. More usually, however, mood disorder worsens physical ill health more indirectly, by interfering with compliance and participation in rehabilitation and by associated poor diet, lack of exercise and overall poorer self-care.
Depression and physical illness with a common cause
Occasionally physical illness and the depressive illness can be seen to share a common cause; e.g. a sequence of stressful life events acting as precipitants to both a myocardial infarction and an episode of depression.
the symptoms of Depression
Depressive illnesses can present in a multitude of ways, including apparent low mood or tearfulness, expressions of hopelessness about recovery, lack of interest in rehabilitation, apparent personality change, irritability or aggression. There may be an increase in somatic complaints despite no apparent worsening of the underlying physical condition or apparent cognitive impairment (pseudo-dementia). Nursing staff are often more alert to such symptoms than medical staff, who may see the patient only briefly and who will inevitably focus on physical symptoms.
Depressive illness is a recognised clinical syndrome rather than a specific diagnosis, and currently the exact aetiology and pathology are unknown. There is hence no definitive diagnostic test available. The diagnosis of depression is made on the basis of operational diagnostic criteria. The two best known and most frequently used are the International Classification of Diseases (ICD-10), published by the World Health Organization and used around the world, and the Diagnostic and Statistical Manual (DSM-IV), published by the American Psychiatric Association and used in the USA and for research purposes (see Table 2 ).
However diagnosed, all depressive disorders are characterised by a lowering of mood which is severe and persistent. Further diagnostic symptoms can be divided into three main areas: diminished mood/enjoyment, biological depressive features and depressive cognitions.
Differential Diagnosis of Depression in physical illness
Because they are broad clinically described syndromes rather than specific disorders, the differential diagnosis for mental disorders is usually short. In patients with physical illness the main distinction to be made is between the physical illness alone (with some of its manifestations, e.g. insomnia or bradykinesia, presenting as apparent depression) and true co-morbid depressive illness. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide
At least five of the above symptoms, and at least one of the symptoms marked (*) must have been present for the previous two weeks for a DSM-IV diagnosis of major depressive episodes. Symptoms can be identified by subjective report or objective observation.
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The biological depressive features of insomnia, loss of appetite, poorer concentration and memory, and lack of libido are much less diagnostically useful in patients with physical illness due to the possibility of diagnostic confusion with symptoms of the physical disorder itself. Subjectively described and objectively observed low mood (particularly if pervasive and with characteristic diurnal variation) and depressive cognitions are of much more diagnostic value.
Conditions to be considered in the differential diagnosis include:
• 
assessment of patients with apparent Depressive symptoms
Clinicians should have a low index of suspicion for the diagnosis of depression in the physically ill. A major determinant as to whether depressive illness will be diagnosed is the willingness of the medical team to ask about symptoms and the whole treating team to be alert to the possibility (see Table 3 ).
When assessing patients with apparent low mood, care should be taken to ensure the right environment for the assessment. There should be sufficient privacy to allow discussion of sensitive topics and sufficient time available to allow for full discussion without 'feeling rushed'. Often the interview will break from a formal structure in order to follow up information as it becomes available. In general, however, one should try to cover the following areas:
• Are there signs of cognitive impairment? Particularly in inpatients, an apathetic, 'depressed' presentation may represent hypoactive delirium. Consider performing a basic test of cognitive function (e.g. AMT, MMSE).
• How does the patient himself describe his mood?
Depression is a cognitive process and its symptoms are subjective experiences. Sometimes patients 'look depressed' but are not; the reverse, of course, can also be true. Ask about diurnal variation in mood. In depressed patients the mood is often lowest in the morning, with improvement later in the day.
• Consider the core and other symptoms of depression described above. The biological depressive features are often less useful in patients with physical illness as they may be mimicked or masked by the symptoms of the physical illness. Nonetheless they should be asked about (see Table 4 ). Is there impairment of sleep, appetite, energy levels, concentration and libido? • The most important features diagnostically are the cognitive features, particularly patients' view of the future: are they hopeless about the prospects for physical recovery? Have they lost the ability to enjoy formerly pleasurable activities (anhedonia)? Their activities may, of course, be limited by physical ill health, but, for example, are they still able to enjoy family visits? • If possible try to talk to family members or others who know the patient well, who may be able to comment on the patient's current mood, previous treatment and severity.
• Screening tools such as the Hospital Anxiety and Depression Scale (HADS), the Beck Depression Inventory (BDI) and the Geriatric Depression Scale (GDS) can be useful in assessing the severity of disorder and measuring improvement, but do not replace clinical assessment in diagnosis. 
Psychological treatments
Psychological treatments (or 'talking therapies') are effective and widely used to treat mood disorders. There are a range of different psychological therapies each with its own rationale and method: examples include cognitive behavioural therapy (CBT), interpersonal therapy (IPT), dynamic (e.g. Freudian) therapy and group therapies. A major determinant in therapy choice will often be local availability and waiting times.
Psychological treatments have some advantages in treating depression in the physically ill in that they avoid the risk of drug interactions or drug side effects. Unfortunately, there are often significant practical difficulties in organising regular therapy attendance (e.g. for an hour per week for many weeks) for patients with physical health problems. Additionally such therapies often have long waiting times, or are simply unavailable in many areas.
Drug treatment
Antidepressant drug treatments are effective in the treatment and prophylaxis of depressive illness. These drugs are usually well tolerated, even in patients with physical illnesses, and do not induce physical dependence. Antidepressant drug treatment should be considered in patients with persisting depressive symptoms that are interfering with their quality of life or overall function.
Antidepressant drugs fall into two broad classes by pharmacological action: those that increase the amount of intrasynaptic neurotransmitter by blocking presynaptic reuptake, such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), and those that increase the amount of intrasynaptic neurotransmitter by blocking its breakdown, the monoamine oxidase inhibitors (MAOIs). Clinically, however, one tends to consider four groupings: SSRIs (e.g. fluoxetine, citalopram), TCAs (e.g. imipramine, amitriptyline), MAOIs (e.g. phenelzine, moclobemide) and other, novel drugs (e.g. venlafaxine, mirtazapine).
In current clinical practice SSRIs are generally first-line drugs, with newer antidepressants used as second-line drugs for SSRI non-responders, and TCAs and MAOIs used in treatment-resistant cases. Where a patient has a history of a previous good response to an antidepressant, that drug is usually considered the first choice drug for them in future episodes of depression. Antidepressants have a slow onset of action and clinical response cannot be expected before 14-21 days after starting the drug.
For patients with physical illness, particularly if there is liver or kidney impairment, drugs may have to be introduced at a lower starting dose and increased in dose more cautiously. The British National Formulary and the Psychotropic Drug Directory are invaluable sources of guidance for decisions regarding psychotropic prescribing.
Drug treatment in specific disorders
• Heart disease There is a significant increase in the incidence of depression in patients following myocardial infarction (MI) which is associated with an increased mortality. Antidepressants are best avoided in the first month after MI; where necessary SSRIs are the first-line drugs. Selective serotonin reuptake inhibitors are also first-line in patients at risk of arrhythmias. • Depressive illness is a common disorder which occurs much more frequently in those with physical illness than in the population at large.
• It is diagnosed using operational diagnostic criteria such as pervasive low mood and loss of the ability to experience pleasure, coupled with biological features of depression and depressive cognitions.
• Co-morbid depression is associated with poorer outcomes in physical illness, with increased morbidity, decreased functional level, increased healthcare costs and overall increased mortality.
• Depression is under-recognised in medical patients but, with increased awareness and some modification of diagnostic methods, can be successfully identified.
• Psychological and drug treatments are available that are effective in depression. Successful treatment is associated with improved quality of life and improved outcomes for the physical disease.
further reaDing This two-day UK Consensus Conference, organised by the RCPE using evidence-based background papers and oral presentations, will produce a final consensus statement to influence diabetes care. Interactive discussions will help shape the final statement.
A multidisciplinary panel, chaired by Professor Roland Jung, Honorary Professor in Medicine at the University of Dundee and Visiting Professor at the University of Southampton, will address the following key questions:
< Who can prevent diabetes? < What are the practical implications of developments in genetics? < Which psychological interventions work? < What after metformin -who cares? < What are the best models of care for children and adolescents?
Abstracts based on the key questions are invited for poster presentation and should be submitted by Monday 1 March 2010.
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